Zollinger Ellison Syndrome Flashcards
Cause of ZES
- non beta islet cell, gastrin secreting tumor
- may occur sporadically (75%) or as part of MEN1 (25%) (autosomal dominant familial syndrome)
Primary tumor of ZES location
Duodenum
Pancreas
Abdominal lymph nodes
Ectopic (heart, gallbladder, liver, kidney)
Pathophysiology of ZES
Gastrinoma causes hypergastrinemia
Increase in number of parietal cells,
Increased maximal acid output
Gastrin also increases basal acid secretion
Also leads to diarrhea and malabsorption ( inactivation of pancreatic enzymes and precipitation of vile salts)
MEN 1 - Wermer’s syndrome
Hyperparathyroidism Pancreatic endocrine tumors Pituaitary tumors (galactinome, GH)
ZES in duodenal ulcers
0.1 - 1 % of patients with duodenal ulcers.
ZES age of onset
40s for ZES 30s for MEN1/ZES 5-7 year delay to diagnosis 3% are younger than 20 years 7% are older than 60 years of age
Survival of ZES
without metastasis :
80% survival at 15 years
Complications / consequences
5% develop abdominal perforation, gastric outlet obstruction or esophageal stricture, gastro-intestinal bleeding.
Seldom :
- Gastric carcinoids (especially in MEN1)
ZES Anamnesis
Nausea
Vomitting
Gastro-intestinal bleeding
Weight loss
MEN 1 Anamnesis
Nephrolithiasis Hypercalcemia Pituitary disorders Fam Hx : - Nephrolithiasis - Hyperparathyroidism - Gastrinoma
ZES physical exam
Pale if gastro-intestinal bleeding Jaundice if compression of common bile duct (rare) Epigastric tenderness Dental erosion Hepatomegaly if liver metastasis
Lab Studies
- Fasting serum gastrin levels 3x, diff days (no PPI, serial measurements, )
Serum calcium (if elevated search for MEN1) - Basal gastric secretory volum > 140ml
Gastric pH < 2 and >140ml over 1h is highly suggestive of ZES - Secretin stimulation test:
- fasting night
- 2U/kg of secretin
- gastrin levels measured at 0,2,5,10,15 min
- >200pg/ml is diagnostic - Somatostatin receptor scintigraphy (SRS)
- Stage and localize (DOTATATE PETCT)